Florence Schleich (Liège, Belgium), Fabio L. M. Ricciardolo (Orbassano (Turin), Italy), Todor Popov (Sofia, Bulgaria), Anna- Carin Olin (Gothenburg, Sweden)
Can cys-LT, PG-D2, PG-E2, IL-5 and ADAM33 levels and their correlation with pulmonary function be discriminative in asthma, COPD and ACOS? Bilun Gemicioglu (Istanbul, Turkey), Gulfidan Cakmak, Bilun Gemicioglu, Yasemin Erdogan Doventas, Macit Koldas
| |
Can blood eosinophils predict sputum eosinophils in stable COPD? Netsanet Negewo (Newcastle, Australia), Netsanet Negewo, Vanessa McDonald, Katherine Baines, Peter Wark, Jodie Simpson, Paul Jones, Peter Gibson
| |
Oxidative stress and biomarkers in patients with bronchial asthma Keitaro Nakamoto (Tokyo, Japan), Keitaro Nakamoto, Hiroo Wada, Shingo Tsuji, Mitsuru Sada, Toshiya Inui, Masuo Nakamura, Kojiro Honda, Yasutaka Tanaka, Takashi Koide, Saori Takata, Masato Watanabe, Takuma Yokoyama, Takeshi Saraya, Daisuke Kurai, Haruyuki Ishii, Hajime Takizawa
| |
Rheumatoid factor as the new predictive marker of reduced lung function: A cross-sectional study Jae-Uk Song (Seoul , Republic of Korea), Jae-Uk Song, Joong Kyong Ahn, Hye Kyeong Park, Yun Su Sim
| |
Serum levels of RAAS components in COPD Ümran Toru (Kütahya, Turkey), Ümran Toru, Ceylan Ayada, Osman Genç, Server Sahin, Özlem Arik, Ismet Bulut
| |
Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis? Hanine Al Kayal (Machghara, West Bekaa, Lebanon), Hanine Al Kayal, Hassan Abu Bass, Ahmad El Sabbah, Wiam Ramadan, Hassan Khachfe, Khalil Al Kwatly, Wissam H. Joumaa
| |
Investigation the role of pentraxin-3 in the innate immune system in patients with COPD Mona Bafadhel (Oxford, United Kingdom), Madiha Dilpazir, Samantha Thulborn, Christopher Brightling, Mona Bafadhel
| |
Short-term stability of the mature elastin degradation biomarker plasma desmosine and influence of smoking on plasma desmosine levels Michiel T.H. Spanbroek (Wijchen, Netherlands), Michiel Spanbroek, Jody Van den Ouweland, Twan Beijers, Henny Van Daal, Richard Dekhuijzen, Rob Janssen
| |
Metabolic syndrome in patients with COPD and their association with systemic inflammation Jain Nirmal Kumar (Jaipur, India), Nirmal Kumar Jain, Nitin Jain, Arpit Sharma
| |
Exploring the volatome of different cancer cell lines Pierre-Hugues Stefanuto (Liège, Belgium), Pierre-Hugues Stefanuto, Romain Pesesse, Virginie Bertrand, Marie-Claire Depauw-Gillet, Jean-François Focant
| |
eTRIKS IT platfroms for large-scale biomedical research Ioannis Pandis (London, United Kingdom), I. Pandis, Y. Guo, F. Guitton, X. Yang, K. Sun, S. Wang, N. Jullian, A.R. Sousa, A.T. Bansal, J. Corfield, S. Pavlidis, P.P. Hekking, L.J. Fleming, D. Shaw, G. Roberts, N. Fitch, J.H. Riley, S.S. Wagers, A. Rowe, I.M. Adcock, K.F. Chung, C. Auffray, P.J. Sterk, The U-BIOPRED Study Group
| |
Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease Juan R Fernández-Lahera Martínez (Madrid, Spain), J. Fernández-Lahera, D. Romera, A. Gómez Mendieta, A. Martínez Verdasco, J. Fernández-Bujarrabal, A. Santiago, S. Alcolea, Y. Martínez-Abad, C. Prados, C. Villasante, R. Alvarez-Sala
| |
A cross-sectional study on association between stable COPD & metabolic syndrome (Syndrome X) Angshuman Mukherjee (Kolkata, India), Angshuman Mukherjee, Samim Khan, Sumitra Basuthakur, Raja Dhar
| |
Neutrophils and spirometry changes in COPD patients treated with roflumilast Konstantinos Porpodis (Thessaloniki, Greece), Kalliopi Domvri, Konstantinos Porpodis, Antonis Papaioannou, Paul Zarogoulidis, Dimitrios Dimitrios Petridis, Olga Hatzizisi, Alexandra Liaka, Violeta Kikidaki, Sofia Lampaki, Ioannis Organtzis, Konstantinos Zarogoulidis
| |
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Celeste M. Porsbjerg (Copenhagen, Denmark), Celeste Porsbjerg, Asger Sverrild, Vibeke Backer
| |
Utility of BAP-65 score in assessing the severity and predicting the outcome in acute exacerbation of COPD, in a tertiary care hospital in South India Kapali Siva K (Chennai, India), Kapali Siva Kumaraguru, Gayathri Anur Ramakrishnan
| |
Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids namrata saxena (Mumbai, India), Namrata Kewalramani, Sujeet Rajan, Sanjeet Marik
| |
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD Nejat Altintas (Samsun, Turkey), Aziz Gumus, Nejat Altintas, Halit Cinarka, Aynur Kirbas, Muge Haziroglu, Mevlut Karatas, Unal Sahin
| |
Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease Gülistan Karadeniz (Izmir, Turkey), Gülistan Karadeniz, Serir Aktogu, Onur Fevzi Erer, Serpil Bulaç Kir, Sibel Doruk, Melike Demir
| |
Higher BODE Index in COPD patients correlated with higher number of comorbidities Mohit Bhatia (Ghaziabad, India), Mohit Bhatia, J.K. Samaria, Ashvendra Singh Chawra
| |